Accurate Investment Solutions’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,222
Closed -$247K 164
2020
Q1
$247K Sell
5,222
-895
-15% -$47.7K 0.2% 71
2019
Q4
$359K Buy
6,117
+4,446
+266% +$247K 0.23% 45
2019
Q3
$89K Buy
1,671
+2
+0.1% +$103 0.07% 93
2019
Q2
$84K Buy
1,669
+3
+0.2% +$151 0.06% 91
2019
Q1
$87K Buy
1,666
+1
+0.1% +$50 0.07% 86
2018
Q4
$79K Buy
1,665
+3
+0.2% +$148 0.07% 85
2018
Q3
$83K Sell
1,662
-8
-0.5% -$406 0.06% 100
2018
Q2
$84K Buy
1,670
+3
+0.2% +$151 0.06% 111
2018
Q1
$81K Buy
1,667
+2
+0.1% +$93 0.06% 103
2017
Q4
$73K Buy
1,665
+2
+0.1% +$92 0.05% 110
2017
Q3
$84K Buy
1,663
+12
+0.7% +$609 0.06% 100
2017
Q2
$89K Buy
1,651
+1
+0.1% +$53 0.07% 91
2017
Q1
$87K Buy
1,650
+80
+5% +$4.06K 0.07% 79
2016
Q4
$76K Buy
1,570
+80
+5% +$3.95K 0.07% 89
2016
Q3
$80K Hold
1,490
0.07% 86
2016
Q2
$81K Sell
1,490
-2,444
-62% -$129K 0.09% 79
2016
Q1
$199K Buy
3,934
+2,380
+153% +$119K 0.19% 49
2015
Q4
$78K Buy
+1,554
New +$79.2K 0.07% 87

Other funds holding GSK

Accurate Investment Solutions's GSK Position: Q2 2020 in Review

Accurate Investment Solutions sold out of GSK (GSK) in Q2 2020, closing a stake of 5,222 shares — an estimated $247K sold.

Accurate Investment Solutions first reported a position in GSK in Q4 2015 and held it in 18 quarters. The position peaked at $359K in Q4 2019. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Accurate Investment Solutions reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 5,222 GSK shares in Q2 2020, an estimated $247K.
  • Accurate Investment Solutions first reported a position in GSK in Q4 2015 and held it in 18 quarters.
  • Accurate Investment Solutions's GSK position peaked at $359K in Q4 2019.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.